Net Income

New 2025 data shows contractors using platforms like ServiceTrade cut emergency calls 27% and boost margins, proving the ROI of a data-driven model.

TransCode Therapeutics and Quantum Leap are targeting hidden cancer cells with a novel RNA drug in a pivotal trial that could prevent colorectal cancer relapse.

A new survey reveals 84% of firms doubt they can pass an AI compliance audit, exposing a massive security gap as autonomous agent adoption surges.

The nation's top infectious disease lab partners with SYNERGEN Health, using AI to combat claim denials and future-proof its national expansion.

BlackRock's integration of Preqin data into its eFront platform creates a single, AI-driven solution, bringing public market transparency to private assets.

Despite product withdrawals, a lack of regulation and the long latency of asbestos-related diseases mean the danger from talc exposure is far from over.

WealthTech firm BizEquity targets the Great Wealth Transfer with a new brand and AI-powered platform to help advisors value and plan for business owner clients.

Pilot Fiber's acquisition of Extenet's enterprise fiber business expands its reach into NJ, targeting the high-stakes finance and AI sectors.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

A new report reveals how GLP-1 drugs are accelerating a major healthcare shift in the Gulf, turning metabolic health into a core economic and policy issue.

Despite currency woes and a tough market, the access solutions giant posts record sales and income, fueled by strategic acquisitions and innovation.

A ₹167 crore deal transforms the TVS Group founder's original land into a modern development, marking a new chapter for Madurai's heritage and real estate.

Kling AI's new 3.0 models promise photorealistic video with unprecedented consistency, challenging rivals and reshaping creative industries.

The South Korean tobacco giant hits record revenue as its international strategy pays off, while it diversifies into nicotine pouches for future growth.

Positive study results for Alvotech's Entyvio biosimilar could disrupt the IBD market, promising lower costs for a blockbuster chronic care treatment.

Bahrain's hospitality giant leverages five decades of experience to challenge the institutional catering sector with a new, tech-driven, large-scale operation.

ASUS unveils the ROG Strix GS-BE7200, a WiFi 7 router promising elite gaming performance and smart home features at an accessible price point.

Volvo Cars' Q4 profits fell, but a tough cost-cutting plan boosted cash flow, setting the stage for its critical electric vehicle push in a tough market.

Futures designer Nick Foster joins Unlikely Collaborators to challenge prediction, urging us to examine the hidden biases that shape what we see as possible.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?